Profil
Chang Rung Chen was the founder of Processa Pharmaceuticals, Inc. (founded in 2011) where he held the title of Senior Director-Translational Science until 2022.
He also held the position of Director-Bimolecular Discovery at ArQule, Inc. and Director-Translational Research & Pharmacology at Questcor Pharmaceuticals, Inc. from 2015 to 2016.
Dr. Chen received his graduate and doctorate degrees from New York University and his undergraduate degree from Tunghai University.
Anciens postes connus de Chang Rung Chen
| Sociétés | Poste | Fin |
|---|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Fondateur | 01/11/2022 |
| QUESTCOR PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2016 |
| ARQULE, INC. | Corporate Officer/Principal | - |
Formation de Chang Rung Chen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
ArQule, Inc.
ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, markets and sells prescription drugs | Health Technology |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tunghai University
Tunghai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
















